SKYSTAR BIO-PHARMACEUTICAL CO Operating Income
SKYSTAR BIO-PHARMACEUTICAL CO reported Operating Income of $5.40 million for the 3-month period ending 2014-09-30, per its 10-Q filed 2014-11-14.
Discontinued › Income Statement
us-gaap:OperatingIncomeLoss · last filed 2014-11-14
- SKYSTAR BIO-PHARMACEUTICAL CO operating income (loss) for the quarter ending 2014-09-30 was $5.40M, a 13.97% increase year-over-year.
- SKYSTAR BIO-PHARMACEUTICAL CO operating income (loss) for the quarter ending 2014-06-30 was $3.37M, a 25.92% decline year-over-year.
- SKYSTAR BIO-PHARMACEUTICAL CO operating income (loss) for the quarter ending 2014-03-31 was $1.17M, a 9.54% increase year-over-year.
- SKYSTAR BIO-PHARMACEUTICAL CO operating income (loss) for the quarter ending 2013-12-31 was $2.66M, a 1636.68% increase year-over-year.
- SKYSTAR BIO-PHARMACEUTICAL CO operating income (loss) for fiscal 2013 was $13.01M, a 52.18% increase from fiscal 2012.
- SKYSTAR BIO-PHARMACEUTICAL CO operating income (loss) for fiscal 2012 was $8.55M, a 43.93% decline from fiscal 2011.
- SKYSTAR BIO-PHARMACEUTICAL CO operating income (loss) for fiscal 2011 was $15.25M, a 15.79% decline from fiscal 2010.
- SKYSTAR BIO-PHARMACEUTICAL CO operating income (loss) for fiscal 2010 was $18.11M.
| Period end | Operating Income (Loss) 3 month | Operating Income (Loss) 6 month | Operating Income (Loss) 9 month | Operating Income (Loss) 12 month |
|---|---|---|---|---|
| 2014-09-30 | $5.40M 10-Q · filed 2014-11-14 | $8.77M derived: sum of 2 quarters · filed 2014-11-14 | $9.94M 10-Q · filed 2014-11-14 | $12.60M derived: sum of 4 quarters · filed 2014-11-14 |
| 2014-06-30 | $3.37M 10-Q · filed 2014-08-14 | $4.54M 10-Q · filed 2014-08-14 | $7.20M derived: sum of 3 quarters · filed 2014-08-14 | $11.94M derived: sum of 4 quarters · filed 2014-11-14 |
| 2014-03-31 | $1.17M 10-Q · filed 2014-05-15 | $3.83M derived: sum of 2 quarters · filed 2014-05-15 | $8.57M derived: sum of 3 quarters · filed 2014-11-14 | $13.11M derived: sum of 4 quarters · filed 2014-11-14 |
| 2013-12-31 | $2.66M derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-31 | $7.40M derived: sum of 2 quarters · filed 2014-11-14 | $11.94M derived: sum of 3 quarters · filed 2014-11-14 | $13.01M 10-K · filed 2014-03-31 |
| 2013-09-30 | $4.74M 10-Q · filed 2014-11-14 | $9.28M derived: sum of 2 quarters · filed 2014-11-14 | $10.35M 10-Q · filed 2014-11-14 | $10.51M derived: sum of 4 quarters · filed 2014-11-14 |
| 2013-06-30 | $4.55M 10-Q · filed 2014-08-14 | $5.62M 10-Q · filed 2014-08-14 | $5.77M derived: sum of 3 quarters · filed 2014-08-14 | $9.41M derived: sum of 4 quarters · filed 2014-08-14 |
| 2013-03-31 | $1.07M 10-Q · filed 2014-05-15 | $1.22M derived: sum of 2 quarters · filed 2014-05-15 | $4.86M derived: sum of 3 quarters · filed 2014-05-15 | $7.15M derived: sum of 4 quarters · filed 2014-05-15 |
| 2012-12-31 | $153.09K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-31 | $3.79M derived: sum of 2 quarters · filed 2014-03-31 | $6.08M derived: sum of 3 quarters · filed 2014-03-31 | $8.55M 10-K · filed 2014-03-31 |
| 2012-09-30 | $3.64M 10-Q · filed 2013-11-14 | $5.93M derived: sum of 2 quarters · filed 2013-11-14 | $8.40M 10-Q · filed 2013-11-14 | $11.49M derived: sum of 4 quarters · filed 2013-11-14 |
| 2012-06-30 | $2.29M 10-Q · filed 2013-08-14 | $4.76M 10-Q · filed 2013-08-14 | $7.85M derived: sum of 3 quarters · filed 2013-08-14 | $16.83M derived: sum of 4 quarters · filed 2013-08-14 |
| 2012-03-31 | $2.47M 10-Q · filed 2013-05-15 | $5.56M derived: sum of 2 quarters · filed 2013-05-15 | $14.54M derived: sum of 3 quarters · filed 2013-05-15 | $16.07M derived: sum of 4 quarters · filed 2013-05-15 |
| 2011-12-31 | $3.10M derived: 10-K 12 month − 10-Q 9 month · filed 2013-04-01 | $12.07M derived: sum of 2 quarters · filed 2013-04-01 | $13.61M derived: sum of 3 quarters · filed 2013-04-01 | $15.25M 10-K · filed 2013-04-01 |
| 2011-09-30 | $8.98M 10-Q · filed 2012-11-14 | $10.51M derived: sum of 2 quarters · filed 2012-11-14 | $12.15M 10-Q · filed 2012-11-14 | $17.92M derived: sum of 4 quarters · filed 2012-11-14 |
| 2011-06-30 | $1.53M 10-Q/A · filed 2012-09-13 | $3.18M 10-Q/A · filed 2012-09-13 | $8.94M derived: sum of 3 quarters · filed 2012-09-13 | $16.81M derived: sum of 4 quarters · filed 2012-09-13 |
| 2011-03-31 | $1.64M 10-Q · filed 2012-05-15 | $7.41M derived: sum of 2 quarters · filed 2012-05-15 | $15.27M derived: sum of 3 quarters · filed 2012-05-15 | $18.01M derived: sum of 4 quarters · filed 2012-05-15 |
| 2010-12-31 | $5.76M derived: 10-K 12 month − 10-Q 9 month · filed 2012-03-30 | $13.63M derived: sum of 2 quarters · filed 2012-03-30 | $16.37M derived: sum of 3 quarters · filed 2012-03-30 | $18.11M 10-K · filed 2012-03-30 |
| 2010-09-30 | $7.86M 10-Q · filed 2011-11-14 | $10.60M derived: sum of 2 quarters · filed 2011-11-14 | $12.35M 10-Q · filed 2011-11-14 | |
| 2010-06-30 | $2.74M 10-Q/A · filed 2011-09-21 | $4.48M 10-Q/A · filed 2011-09-21 |